Metabolic, electrolytes disorders and tromboembolic risk in malignant glioma patients

[1]  Cheng-Hsien Lu,et al.  Risk Factors of Oxcarbazepine-Induced Hyponatremia in Patients With Epilepsy , 2010, Clinical neuropharmacology.

[2]  D. Schiff,et al.  Venous thromboembolism in malignant gliomas , 2010, Journal of thrombosis and haemostasis : JTH.

[3]  M. Brada,et al.  Radiation-induced hypopituitarism. , 2009, Endocrine-related cancer.

[4]  Ajul Shah,et al.  How to manage steroid diabetes in the patient with cancer. , 2006, The journal of supportive oncology.

[5]  J. Bilezikian,et al.  Perspectives on glucocorticoid-induced osteoporosis. , 2004, Bone.

[6]  J. Bussel,et al.  Hematologic toxicity of sodium valproate. , 2000, Journal of pediatric hematology/oncology.

[7]  Koehler Pj.  Use of corticosteroids in neuro-oncology. , 1995 .

[8]  P. Koehler.  Use of corticosteroids in neuro-oncology. , 1995, Anti-cancer drugs.

[9]  M. Decramer,et al.  Steroid-induced myopathy and its significance to respiratory disease: a known disease rediscovered. , 1992, The European respiratory journal.

[10]  Bergman Ra,et al.  Steroid myopathy. Clinical, histologic and cytologic observations. , 1968 .